Skip to content

Diaphragmatic Function in Ventilated Patients

Ventilator-Induced Diaphragmatic Dysfunction (VIDD) in Critically Ill Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00786526
Enrollment
55
Registered
2008-11-06
Start date
2008-03-31
Completion date
2010-07-31
Last updated
2013-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill

Keywords

Mechanical ventilation, Ventilator induced diaphragmatic dysfunction, Weaning, Neuromuscular diseases- Respiratory function tests, Intubated patients in intensive care unit

Brief summary

Animal studies showed that controlled mechanical ventilation (CMV) can induce dysfunction of the diaphragm, resulting in an early-onset and progressive decrease in diaphragmatic force-generating capacity, called ventilator-induced diaphragmatic dysfunction (VIDD).

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Invasive mechanical ventilation (tracheally intubated or tracheotomized) less than 48h.· * Duration of mechanical ventilation for at least 72h.· * Subject itself or its next of kin has given written informed consent

Exclusion criteria

* Patient is less than 18 years or more than 85 years of age· * The attending physician refuses to allow enrollment· * The patient refuses informed consent * Next of kin is unavailable or refuses informed consent· * Pregnant or breast-feeding female. * A pregnancy test will be performed in all female patients less than 60 years of age.· * Any contraindication to use cervical magnetic stimulation (mechanical cardiac assist device …).· * Presence or suspicion of prior diaphragm injury or chronic disease· * Presence or suspicion of a central nervous system (CNS) disorder, including (but not limited to): CNS infarction, bleeding, tumor, or infection

Design outcomes

Primary

MeasureTime frame
Respiratory function parameters6 weeks

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026